← Lietuva

RESOLUTION OF THE GOVERNMENT

RESOLUTION OF THE GOVERNMENT Official translation GOVERNMENT OF THE REPUBLIC OF LITHUANIA RESOLUTION No. 509 REGARDING THE IMPLEMENTATION OF THE LAW OF THE REPUBLIC OF LITHUANIA ON THE CONTROL OF PRECURSORS OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES 8 May 2000 Vilnius Pursuant to Articles 4, 6, 10, 11 and subparagraphs 1, 2 and 4 of paragraph 1 of Article 16, the Government of the Republic of Lithuania has resolved:

  1. To approve the following attached documents: 1.
  2. The Procedure for licensing, registration and issuing authorisation to engage in activities involving precursors of narcotic drugs and psychotropic substances; 1.
  3. the list of countries to which the export of precursors of narcotic drugs and psychotropic substances, listed in categories II and III, is subject to authorisation.
  4. To authorise the State Medicines Control Agency at the Ministry of Health Care to perform the functions of issue of licenses, registration, issue of authorisations and control of the activities involving precursors of narcotic drugs and psychotropic substances.
  5. To establish that the operators engaged in activities involving precursors of narcotic drugs and psychotropic substances must within 3 months after the coming into force of this Resolution acquire licences or register their activities in compliance with the procedure for licensing, registration and issue of authorisations for activities involving precursors of narcotic drugs and psychotropic substances. PRIME MINISTER ANDRIUS KUBILIUS MINISTER OF HEALTH CARE RAIMUNDAS ALEKNA APPROVED by the Resolution of the Government of the Republic of Lithuania of 8 May 2000 No. 509 PROCEDURE FOR LICENSING, REGISTRATION AND ISSUE OF AUTHORISATIONS FOR ACTIVITIES INVOLVING PRECURSORS OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES I. GENERAL PROVISIONS
  6. The Procedure shall regulate: 1.
  7. the issue of licenses to engage in activities involving precursors of narcotic drugs and psychotropic substances listed in category I, refusal of licences, suspension of licences, revocation of suspension of licence validity, revocation of licences, registration and re-registration of licences; 1.
  8. registration, refusal of registration, suspension of registration validity, revocation of suspension of registration validity, revocation of validity, issue of registration certificate for activities involving precursors of narcotic drugs and psychotropic substances listed in categories II and the export of precursors of narcotic drugs and psychotropic substances listed in category III to countries the list whereof is approved by the Government of the Republic of Lithuania, if the weight of the exported consignment of precursors exceeds the weight established by the Ministry of Health Care of the Republic of Lithuania; 1.
  9. issue of authorisations for import, export, transit of precursors of narcotic drugs and psychotropic substances listed in category I, export of precursors of narcotic drugs and psychotropic substances listed in categories II and III to countries the list whereof is approved by the Government of the Republic of Lithuania, if the weight of the exported consignment of precursors exceeds the weight established by the Ministry of Health Care of the Republic of Lithuania.
  10. The word “precursor” shall be used hereinafter instead of the words “precursors of narcotic drugs and psychotropic substances”. PROCEDURE FOR LICENSING OF ACTIVIITIES INVOLVING PRECURSORS LISTED IN CATEGORY I Types of licences
  11. The following types of licences to engage in activities involving precursors listed in category I shall be established: 3.
  12. the licence to engage in the manufacture, processing of precursors listed in category I; 3.
  13. the licence to engage in wholesale of precursors listed in category I, including broking, as well as import, export and transit thereof; 3.
  14. the licence to engage in storage in warehouses of precursors listed in category I.
  15. Having acquired a licence to engage in the manufacture, processing of precursors listed in category I, the operator shall also have the right to sell his products by wholesale, to export and store the products in a warehouse.
  16. the operator who wishes to engage in the activities involving precursors listed in category I in several facilities or premises shall be issued one licence in which the addresses of the facilities and premises where it is permitted to engage in the above activities shall be indicated.
  17. Licences to engage in the activities involving precursors listed in category I shall be issued, licences shall be suspended, suspension of licences shall be revoked, licences shall be revoked and licences shall be registered or re-registered by the State Medicines Control Agency at the Ministry of Health Care (hereinafter referred to as the State Medicines Control Agency). Licences shall be signed by the head of the State Medicines Control Agency endorsing them by the official seal. Documents Required for being Issued a Licence or for Re-registering the licence
  18. The operator who wishes to be issued a licence to engage in the activities involving precursors listed in category I shall file an application with the State Medicines Control Agency of the form prescribed by the Agency. The following must be specified in the application: 7.
  19. the name of the operator, the address of the registered office, telephone and fax numbers, the enterprise registration number (for legal persons and enterprises without the rights of a legal person) or the name and surname, address, personal code number, telephone and fax numbers (for natural persons); 7.
  20. addresses of the facilities or premises where the activities will be engaged in; 7.
  21. the type of licence applied for; 7.
  22. the names of the precursors which are to be involved in the appropriate activities; 7.
  23. the date of filing of the application; 7.
  24. the name, surname, qualifications, official duties, telephone number of the person responsible for the activities subject to licensing.
  25. The following documents shall be attached to the application: 8.
  26. copies of the operator’s registration certificate and bylaws (regulations) (for legal persons and enterprises without the rights of a legal person) or name, surname, personal code, telephone and fax numbers (for natural persons); 8.
  27. copies of the licence to engage in pharmaceutical activities for the operator who is engaged in pharmaceutical activities involving precursors; 8.
  28. a copy of the deed of commissioning of facilities and premises in which the activities involving precursors listed in category I are intended to be carried out, whereas for the operators, engaged in pharmaceutical activities involving precursors listed in category I - a certificate of the State Medicines Control Agency concerning the condition and suitability for use of the facilities and premises intended for the activities involving precursors listed in category I; 8.4.a certificate issued by the State Tax Inspectorate under the Ministry of Finance (hereinafter referred to as the State Tax Inspectorate) testifying that the operator has made the required payments into the State Budget of the Republic of Lithuania, municipal budgets and funds, payments into which are administered by the State Tax Inspectorate, also a certificate issued by the State Social Insurance Fund Board verifying that the operator has no arrears of payments due to the State Social Insurance Fund. The certificates must be issued not earlier than 30 days prior to the day of filing of the application for a licence. 8.
  29. a copy of the authorisation - hygiene certificate to engage in commercial-economic activities; 8.
  30. payment order stamped by the bank or the receipt confirming the payment of the established amount of stamp duty (submitted following the making of the decision to issue or re-register a licence).
  31. In order to have the licence re-registered, the State Medicines Control Agency shall be submitted documents specified in items 7 and 8.4 of this Procedure, the licence re-registration whereof is applied for and, after the State Medicines Control Agency makes a decision to re-register the licence, documents specified in paragraph8.
  33. For the purpose of changing the assortment of precursors or the addressees of the premises where the activities are carried out, the licence possessed has been supplemented.
  34. In order to supplement the possessed licence, the operator shall file an application with the State Medicines Control Agency where new names of the precursors or addresses of the facilities and premises will be indicated. In case the addresses of the facilities or premises have changed, the documents specified in paragraph8.3 of this Procedure shall be attached to the application. The licence shall be supplemented within the time limits specified in paragraph12 of this Procedure. Examination of Documents Required for the Issuance or Re-registration of Licences, Refusal to Issue or Re-register a Licence
  35. Having examined the filed application, the State Medicines Control Agency shall not later than within 30 calendar days from the filing of all the required documents adopt one of the following decisions: 12.
  36. to issue a licence; 12.
  37. to refuse issuing a licence; 12.
  38. to re-register a licence; 12.
  39. to refuse re-registering a licence.
  40. Licences shall be issued for an indefinite period and are subject to re-registration every 5 years.
  41. Stamp duty shall be payable for the issuance and re-registration of the licence in accordance with the procedure laid down by the Law of the Republic of Lithuania on Stamp Duty and Resolutions of the Government of the Republic of Lithuania.
  42. The State Medicines Control Agency shall issue the operator who has lost its licence and published a notice to the effect in the press with a duplicate copy marked “Dublikatas” after the latter presents a substantiated explanation in writing.
  43. The licence shall not be issued or re-registered if: 16.
  44. not all required documents are presented or the presented documents do not meet the established requirements; 16.
  45. the supervising state institutions have established violations in the operator’s activities involving precursor and the violations have not been remedied.
  46. The State Medicines Control Agency shall notify the applicant in writing of the decision to refuse to issue or re-register the licence within 10 calendar days from the day of adoption of the decision, stating the reasons thereof.
  47. Having eliminated the reasons precluding the issue of the licence, the operator may repeatedly apply to the State Medicines Control Agency. The operator’s application and other required documents shall be considered in accordance with the general procedure. Requisites of the Form of the Licence
  48. The form of the licence shall be approved by the State Medicines Control Agency.
  49. the following shall be specified in the licence: 20.
  50. the name of the institution which issued the licence; 20.
  51. the name and number of the licence; 20.
  52. the name of the licence holder and the registration number (for legal persons and enterprises without the rights of a legal person) or the name, surname and personal code (for natural persons); 20.
  53. the type of the licence; 20.
  54. the names of the precursors, activities involving which are authorised; 20.
  55. the dates of issue and re-registration of the licence; 20.
  56. addresses of facilities and premise where engaging in appropriate activities is authorised. Rights of the Licence Holder
  57. The licence holder shall have the following rights: 21.
  58. to engage in the activities specified in the licence involving the precursors indicated in the licence; 21.
  59. to demand explanations from the State Medicines Control Agency regarding the suspension of the licences, revocation of the licence, refusal to issue or re-register the licence; 21.
  60. to appeal in the manner laid down by law against the decisions of the State Medicines Control Agency to suspend the licence, to revoke the licences, to refuse to issue or re-register the licences. Duties of the Licence Holder
  61. Carrying out the activities subject to licensing, the licence holder must: 22.
  62. act in compliance with the international agreements, laws of the Republic of Lithuania, resolutions of the Government of the Republic of Lithuania, other legal statutes which regulate the activities subject to licensing and this Procedure; 22.
  63. while engaging in pharmaceutical activities involving precursors of substances, comply with the legal acts regulating pharmaceutical activities and the requirements laid down therein; 22.
  64. ensure the security of precursors, apply production technologies and equipment which meet safety requirements; 22.
  65. carry out activities involving only the precursors specified in the licence and only in the facilities and premises indicated in the licence; 22.
  66. manufacture, process, keep in storage (or engage in the wholesale, import, export or transit) only those precursors, the acquisition whereof is confirmed by the documents having legal force and the quality whereof is confirmed by documents; 22.
  67. if the person responsible for the activities involving precursors is replaced, notify thereof the State Medicines Control Agency within 10 days of the appointment of the new responsible person; 22.
  68. furnish the requested information and documents to the state institutions which supervise the activities subject to licensing and ensure for them conditions for unobstructed supervision of the above activities. Suspension of Licence, Revocation of Suspension and Revocation of Licence
  69. The licence shall be suspended if: 23.
  70. the supervising state institutions notify in writing that the holder of the licence fails to fulfil the duties of the licence holder; 23.
  71. it transpires that incorrect data has been submitted for the issuance of the licence. 24 The State Medicines Control Agency shall within 10 days notify the operator in writing of the adopted decision to suspend the licence and shall indicate the reasons for the suspension of the licence. Upon the suspension of the licence the operator must eliminate the established reasons of licence suspension within 3 months following the suspension of the licence. Taking into account the character of the violation, the State Medicines Control Agency shall set the specific time period for the elimination thereof.
  72. The suspension of the licence shall be revoked after the elimination of the violations for reason whereof the licence has been suspended.
  73. The licence shall be revoked if: 26.
  74. the supervising state institutions ascertain violations of the activities subject to licensing; 26.
  75. the operator whose licence has been suspended fails to remedy within the set time period the violations for reason whereof the licence has been suspended; 26.
  76. the supervising state institutions notify in writing of the operator’s false accounting and tax evasion; 26.
  77. the court judgement convicting the person of crimes involving narcotic drugs and psychotropic substances and their precursors becomes effective (if the operator engaged in the activities involving precursors is a natural person); 26.
  78. the operator is put into liquidation, goes bankrupt or is subject to reorganisation; 26.
  79. the operator files an application requesting revocation of the licence; 26.
  80. the operator fails to apply for the re-registration of the licence.
  81. The State Medicines Control Agency shall notify the operator in writing of the adopted decision to revoke the licence within 10 calendar days after the adoption of the decision and shall indicate the reasons of revocation.
  82. The operator whose licence has been revoked shall return the licence to the State Medicines Control Agency within 5 working days after the receipt of the notification of revocation.
  83. After the revocation of the licence a new licence may be issued not earlier than after 5 years from the day of licence revocation, except in cases specified in items 26.5 and 26.6 of this Procedure when the licences are issued in accordance with the general procedure. Registration of Licences and Publication of Information regarding the Issue of Licences
  84. The State Medicines Control Agency shall register the licences in the register of licences, which must contain the following data: 30.
  85. licence number; 30.
  86. the date of issue of licence and the date of licence re-registration; 30.
  87. types of licences; 30.
  88. the name of the operator, the address of the registered office, telephone and fax numbers, the enterprise registration number (for legal persons and enterprises without the rights of a legal person) or the name and surname, address, personal code number, telephone and fax numbers (for natural persons); 30.
  89. the addresses of the facilities or premises where the activities will be engaged in; 30.
  90. the date and grounds of revocation of the licence; 30.
  91. the date and reason of the revocation of the licence suspension; 30.
  92. the date and reason of revocation of the licence.
  93. Information on the issue, re-registration, suspension of the licence, revocation of the licence suspension or revocation of the licence shall be published in the “Information Supplement” to the “Official Gazette” not later than within 5 working days after the registration of the operator in the licence register: the following data shall be announced therein: 31.
  94. the name of the operator, the enterprise registration number (for legal persons and enterprise s without the rights of a legal person) or the name, surname and personal code (for natural persons); 31.
  95. the licence number and date of issue; 31.
  96. the date (dates) of licence re-registration; 31.
  97. the dates of licence suspension, revocation of licence suspension and revocation of the licence. Supervision of the Activities Subject to Licensing
  98. The activities subject to licensing shall be monitored and supervised by the State Medicines Control Agency and other supervising state institutions according to their sphere of activity.
  99. In each established case of failure to pay the levies and fees, the territorial state tax inspectorates and state social insurance institutions must inform the State Medicines Control Agency about the arrears in payments of the licence holders.
  100. The customs authorities shall carry out supervision of the export, import and transit of precursors pursuant to the authorisations for import, export and transit, issued by the State Medicines Control Agency.
  101. The supervising state institutions must forthwith inform the licence issuing institution in writing of the established violations of the activities subject to licensing. III. PROCEDURE FOR REGISTERING ACTIVITIES INVOLVING PRECURSORS LISTED IN CATEGORIES II AND III General Conditions for the Registration of Activities and Documents Required for the Registration of Activities
  102. If the weight of the exported consignment of precursors exceeds the weight established by the Ministry of Health Care of the Republic of Lithuania, the operators shall have the right to engage in activities involving the precursors listed in category II and export of precursors listed in category III into the countries the list whereof is approved by the Government of the Republic of Lithuania only after having registered their activities.
  103. The activities specified in paragraph36 of this Procedure shall be registered and re-registered, the registration licences shall be issued, and the validity of registration shall be suspended, suspension of validity shall be revoked and registration shall be invalidated by the State Medicines Control Agency. The registration certificates shall be signed by the head of the State Medicines Control Agency, certifying the same with the official seal.
  104. The operator desirous to register the activities shall file an application with the State Medicines Control Agency, indicating the following: 38.
  105. the name of the operator, the address of the registered office, telephone and fax numbers, the enterprise registration number (for legal persons and enterprises without the rights of a legal person) or the name and surname, address, personal code number, telephone and fax numbers (for natural persons); 38.
  106. the names of the precursors, which will be involved in the intended activities; 38.
  107. the character of the activities according to paragraph 36 of this Procedure; 38.
  108. the addresses of facilities and premises in which activities involving precursors listed in category II or related to the export of precursors listed in category III will be engaged in ; 38.
  109. the name, surname, qualification, official duties, telephone number of the person responsible for the registered activities; 38.
  110. date of filing of the application.
  111. The applications shall be filed with the operator’s registration certificate and copies of the bylaws (regulations) (for legal persons and enterprises without the rights of an enterprise) or copies of the passport (for natural persons) attached thereto.
  112. In case not all documents have been submitted or the data indicated is inaccurate, the State Medicines Control Agency may demand that the data should be revised. Registration or Re-registration of the Activities, Issue of the Registration Certificates
  113. Having received and considered the application and documentation, the State Medicines Control Agency shall adopt a decision concerning the registration or re-registration of the activities no later than within 10 calendar days following the day of receipt of the required documents. If additional documents have been submitted upon the request of the State Medicines Control Agency (pursuant to paragraph 40 of this Procedure), the decision shall be adopted no later than within 10 calendar days after the day of receipt of the revised documents.
  114. After the decision to register the activities has been adopted, the operator shall be issued the registration certificate of the form prescribed by the State Medicines Control Agency.
  115. The following shall be indicated in the registration certificate: 43.
  116. the name of the institution which issued the registration certificate; 43.
  117. the name of the operator and the enterprise registration number (for legal persons and enterprises without the rights of a legal person) or the name and surname, address, personal code number, telephone and fax numbers (for natural persons); 43.
  118. the date of issue and re-registration of the registration certificate; 43.
  119. the number of the registration certificate; 43.
  120. the character of the activities involving precursors; 43.
  121. the names of precursors, the activities involving which are authorised; 43.
  122. the addresses of facilities and premises in which the activities involving precursors listed in category II or related to the export of precursors listed in category III will be engaged in.
  123. The activities shall be registered for an indefinite period and are subject to re-registration every 5 years counting from the day of issue of the registration certificate.
  124. An application and documents specified in paragraph 39 of this Procedure must be submitted in order to have the activities re-registered.
  125. In case not all documents have been submitted for the purpose of re-registration or the data indicated is inaccurate, the State Medicines Control Agency may demand that the documents should be submitted (data should be revised) within 10 calendar days.
  126. The operator shall be refused registration or re-registration of the activities if: 47.
  127. not all required documents have been submitted or the submitted documents do not meet the established requirements; 47.
  128. the supervising state institutions have ascertained violations in the operator’s activities involving precursor and the violations have not been remedied.
  129. The State Medicines Control Agency shall notify the applicant in writing of the refusal to register or re-register the licence within 10 calendar days from the day of adoption of the decision, stating the reasons thereof.
  130. An additional certificate of registration shall be required in order to change the assortment of precursors or the addresses of the facilities or premises where the appropriate activities are engaged in. For the above purpose the operator must file an application with the State Medicines Control Agency where new names of precursors or the addresses of facilities or premises would be indicated. The decision concerning supplementing of the registration certificate shall be adopted within the time limits specified in paragraph 41 of this Procedure. Suspension of Validity of Registration of Activities, Revocation of Suspension of Validity and Revocation of Validity
  131. The validity of registration of activities shall be suspended if: 50.
  132. the operator fails to comply with the Law of the Republic of Lithuania on the Control of Precursors of Narcotic Drugs and Psychotropic Substances and the provisions of this Procedure, although notified in writing by the institutions supervising its activities; 50.
  133. it transpires that incorrect documents have been filed for the registration of the activities.
  134. The operator shall have the suspension of validity of registration revoked if the violations for reason whereof the validity of registration of activities has been suspended are remedied.
  135. The validity or registration of activities shall be revoked if: 52.
  136. the operator files an application requesting revocation of the validity of registration of activities; 52.
  137. the operator goes into liquidation, goes bankrupt or is subjected to reorganisation; 52.
  138. the operator fails to remedy the violations within the prescribed time period; 52.
  139. the operator has not applied for the re-registration of its activities.
  140. Upon the revocation of the validity of registration of activities pursuant to paragraph 52.3 of this Procedure, the repeated registration of activities may be effected not earlier than after the lapse of one year after the revocation of the validity of registration.
  141. The State Medicines Control Agency shall notify the operator in writing of the decision to suspend the registration of activities or to revoke the validity of registration within 10 calendar days from the day of adoption of the decision, stating the reasons thereof.
  142. The operator, the certificate of registration of activities whereof has been revoked, shall return the certificate to the State Medicines Control Agency within 15 days after the receipt of the decision to revoke the validity of registration of the activities. Keeping the Registration Book
  143. The registration certificates, issued to the operators who are registering their activities shall be recorded in the registration book kept by the State Medicines Control Agency.
  144. The following data shall be indicated in the registration book: 57.
  145. the name of the operator, the address of the registered office, telephone and fax numbers, the enterprise registration number (for legal persons and enterprises without the rights of a legal person) or the name and surname, address, personal code number, telephone and fax numbers (for natural persons); 57.
  146. the number of the registration certificate; 57.
  147. the dates of registration and re-registration of the activities; 57.
  148. the address, telephone and fax numbers of the facility and premises where the activities are engaged in; 57.
  149. the character of the operator’s activities involving precursors listed in categories II and III; 57.
  150. the names of precursors, the appropriate activities involving which are authorised; 57.
  151. the date and reasons of the suspension of validity of registration of activities; 57.
  152. the date and reasons of the revocation of suspension of the validity of registration of activities; 57.
  153. the date and reasons of revocation of the validity of activities registration. Publication of Information
  154. Information on the registration and re-registration of activities, issue of registration certificates, suspension of the registration validity, revocation of the suspension of registration validity or revocation of the registration shall be published in the “Information Supplement” to the “Official Gazette” not later than within 5 working days after the registration of the operators in the registration book: the following data shall be indicated therein: 58.
  155. the name of the operator, the enterprise registration number (for legal persons and enterprise s without the rights of a legal person) or the name, surname and personal code (for natural persons); 58.
  156. the number of the registration certificate and date of issue; 58.
  157. the date (dates) of the re-registration of activities; 58.
  158. the date of suspension of the registration validity, revocation of the suspension of registration validity or revocation of the registration validity. IV. PROCEDURE FOR ISSUING IMPORT, EXPORT AND TRANSIT AUTHORISATIONS General Conditions for Issuing Authorisations and Documents Required for being Issued an Authorisation
  159. Every case of the import, export and transit of precursors listed in category I shall be subject to an authorisation.
  160. An authorisation for the import, export and transit of precursors listed in category I shall be issued only to the operators who hold licences specified in paragraphs 3.1 and 3.2 of this Procedure.
  161. The export from the Republic of Lithuania of precursors listed in categories II and III shall be subject to an authorisation only when the precursors of these categories are exported to the those countries the list whereof has been approved by the Government of the Republic of Lithuania and the weight of the exported consignment of precursors exceeds the weight established by the Ministry of Health Care.
  162. An authorisation for the export of precursors listed in categories II and III shall be issued only to those operators who have registered their activities in accordance with the requirements laid down in Chapter III “Procedure for Registering Activities Involving Precursors Listed in Categories II and III” of this Procedure.
  163. Authorisations for the import, export and transit of precursors shall be issued, suspended or revoked by the State Medicines Control Agency. The authorisations shall be signed by the head of the State Medicines Control Agency, certifying the same with the official seal.
  164. An application of the form prescribed by the State Medicines Control Agency must be filed in order to be issued an authorisation for the import, export and transit of precursors; the following must be indicated in the application: 64.
  165. the name of the operator, the enterprise registration number (for legal persons and enterprise s without the rights of a legal person) or the name, surname and personal code (for natural persons); 64.
  166. the number and date of issue of the licence to engage in activities involving precursors listed in category I, or the number and date of the registration certificate; 64.
  167. character of the intended operation involving precursors (import, export, transit); 64.
  168. name of the precursor, the package, its size, the number of packages, commercial name of the mixture, the percentage of the precursor in the mixture, the international or chemical name of the precursor, the weight of the precursor in the consignment; 64.
  169. purpose of application of the imported precursors, the consignee; 64.
  170. manner and route of transportation; 64.
  171. name of the customs office at the border crossing point.
  172. The following document shall be appended to the application: 65.
  173. in order to be issued an authorisation for the export of precursors listed in category I - authorisation for the import issued by the importing country; 65.
  174. for an authorisation for transit - an authorisation for export issued by the exporting country and an authorisation for import issued by the importing country. Issue of Authorisations
  175. The State Medicines Control Agency shall adopt a decision concerning the issue of an authorisation within 10 days after the receipt of the application and all the required documentation.
  176. The form of the authorisation for export, import and transit shall be established by the State Medicines Control Agency. The following must be indicated in the authorisation: 67.
  177. the institution which issues the authorisation; 67.
  178. the number of the authorisation; 67.
  179. requisites of the importer, exporter or performer of the customs transit procedure (carrier); 67.
  180. the date of issue and date of validity of the authorisation; 67.
  181. the name, amount and weight of the precursor, package, percentage of the precursor in the mixture, commercial name and amount of the mixture, the international name of the precursor according to the list of precursors approved by the Ministry of Health Care and the total amount of the precursor; 67.
  182. the name of the customs office at the border crossing point; 67.
  183. means of transportation and the consignee; 67.
  184. the number, date of issue of the authorisation for import of the importing country and the name of the issuing institution- in the authorisation for export; 67.
  185. the number, date of issue of the authorisation for import of the importing country and the name of the issuing institution; the number, date of issue of the authorisation for export and the name of the issuing institution; the names of the customs office at the border crossing point of introduction into and departure from the Republic of Lithuania, means and route of transportation - in the authorisation for transit.
  186. A single authorisation shall be issued for every case of import, export and transit. The term of validity of authorisation shall be as follows: 2 months from the date of issue for authorisations for import and 1 month from the date of issue for authorisations for export and transit.
  187. An authorisation for import shall be issued in 4 copies of which one copy will be left with the State Medicines Control Agency and the remaining 3 shall be issued to the importer. The latter shall send one copy to the exporter and present the remaining copies to the customs office through which the consignment is introduced into the customs territory of the Republic of Lithuania. The stamp of the customs office shall be applied to the authorisations which shall later be produced while executing the customs clearance procedure. One stamped copy of the authorisation shall be attached to the customs declaration (the importer shall keep a Photostat copy), whereas the other stamped copy (the copy of the customs office) shall be sent to the territorial customs authority.
  188. An authorisation for export shall be issued in 4 copies: one copy will be kept by the State Medicines Control Agency, another copy shall be sent by the State Medicines Control Agency to the appropriate institution of the importing country, and the remaining 2 copies shall be issued to the exporter who shall present them to the customs office executing the procedure of export. The customs office shall apply its stamp to the authorisations; one stamped copy shall be appended to the customs declaration, whereas the other copy to which the stamp of the customs office has been applied (the copy of the customs office) shall be sent to the territorial customs authority.
  189. The copies of the authorisations for export, import or transit which are delivered to the territorial customs authorities (copies of the customs office) shall be returned (by registered mail) within a month’s period to the State Medicines Control Agency by the 10th day of the next month.
  190. The unused authorisations must within 10 calendar days after the expiry of the authorisation validity be returned to the State Medicines Control Agency together with a written explanation of the reasons of failure to use them.
  191. The issue of authorisations shall be refused if: 74.
  192. not all the required documents have been presented or those presented have not been duly executed; 74.
  193. there is a written notice of the supervising state institution regarding violations in the operator’s activities involving precursors or violations of the requirements of this Procedure; 74.
  194. applying for an authorisation, the operator submitted fraudulent or incorrect information or the precursors are intended for illegal manufacture of narcotic drugs or psychotropic substances.
  195. The validity of an authorisation shall be suspended when: 75.
  196. the submitted information required under paragraph 64 of this Procedure is incorrect; 75.
  197. the licence or registration of the activities has been suspended; 75.
  198. the supervising state institutions submit a written notification that the operator’s activities involving precursors are in breach of the law.
  199. The suspension of the validity of the authorisation shall be revoked if the violations specified in paragraph 75 of this Procedure, which entailed suspension of the licence, are remedied.
  200. An authorisation shall be revoked in the event of: 77.
  201. failure to submit the report specified in paragraph 80 of this Procedure; 77.
  202. revocation of the licence or registration of the activities; 77.
  203. failure to timely re-register the licence or activities; 77.
  204. failure to remedy the violations which resulted in the suspension of the licence validity; 77.
  205. the operator’s intention to use the precursors for the manufacture of narcotic drugs or psychotropic substances.
  206. In the event of revocation or suspension of the authorisation, or revocation of the suspension of the authorisation, the operator shall be notified thereof within 3 calendar days from the day the decision was made, giving the reasons for the decision.
  207. The operator, whose authorisation for the import, export or transit of has been revoked, must return to the State Medicines Control Agency all copies of the authorisation within 3 calendar days from the receipt of the notice to the effect.
  208. The operators who have been issued authorisations for the import, export or transit must submit reports to the State Medicines Control Agency in the manner prescribed by the Agency on the actual amount of imported and exported precursors: quarterly reports within 15 days after the close of every quarter, annual reports within one month after the close of the year. APPROVED by the Resolution of the Government of the Republic of Lithuania of 8 may 2000 No. 509 COUNTRIES THE EXPORT TO WHICH OF PRECURSORS OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES, LISTED IN CATEGORIES II AND III REQUIRES AN AUTHORISATION Lithuanian name of the precursor International (chemical) name of the precursor CN code Names of countries Precursors listed in category II Acto rûgðties anhidridas Acetic anhydride 2915 24 00 0 Burma Bolivia Equator Guatemala Hong Kong India Iran United Arab Emirates Colombia Lebanon Malaysia Mexico Peru Singapore Syria Thailand Turkey Venezuela Antranito rûgðtis Anthranilic acid 2922 43 00 0 Bolivia Equator India United Arab Emirates Colombia Mexico Peru Venezuela Fenilacto rûgðtis Piperidinas Phenylacetic acid Pepiridine 2916 34 00 0 2933 32 00 0 Bolivia Equator USA United Arab Emirates Colombia Mexico Peru Venezuela Precursors listed in category III Metiletilketonas (MEK) Tokluenas Kalio tetraoksomanganastas Sulfato rûgðtis Methyl ethyl ketone Toluene Potassium permanganate Sulphuric acid 2914 12 00 0 2902 30 2841 61 00 0 2807 00 10 0 Argentine Bolivia Brazil Chile Equator Guatemala Honduras Hong Kong United Arab Emirates Colombia Costa Rica Panama Paraguay Peru Salvador Syria Thailand Uruguay Venezuela Acetonas Etileteris (dietileteris) Acetone Ethyl Ether (Dierthyl ether)) 2914 11 00 0 2909 11 00 0 Argentine Burma Bolivia Brazil Chile Equator Guatemala Honduras Hong Kong Iran United Arab Emirates Colombia Costa Rica Lebanon Mexico Panama Paraguay Peru Salvador Singapore Syria Thailand Turkey Uruguay Venezuela Druskos rûgðtis Hydrochloric acid 2806 10 00 0 Argentine Burma Bolivia Brazil Chile Equator Guatemala Honduras Hong Kong Iran United Arab Emirates Colombia Costa Rica Lebanon Panama Paraguay Peru Salvador Singapore Syria Thailand Turkey Uruguay Venezuela Note. Salts of the above substances, except for sulphuric acid and hydrochloric acid, shall also be assigned to the precursor of narcotic drugs and psychotropic substances, listed in categories II and III.

🔗 Į oficialų šaltinį

DI paaiškinimas pagal oficialų įstatymo tekstą. Orientacinis, nepakeičia teisinės konsultacijos.